Title 31 Fines Hit $75M: Public Records Save Casinos
Learn how public record intelligence enhances casino AML compliance, prevents Title 31 fines, strengthens KYC/EDD, and combats fraud risks.
FDA Eliminates Biosimilar Testing Requirements, Slashing Development Costs
Understand FDA’s Oct. 2025 biosimilar framework that eliminates efficacy studies and cuts $100M+ costs via analytics, streamlines interchangeability for faster market entry.
How Financial Firms Balance AI Speed With Audit Compliance
Discover how financial firms balance AI speed with audit compliance using auditable agentic workflows. Insights from Moody’s and Prudential on regulatory strategies, best practices, and scaling AI in credit and claims.
AI Hiring Tools Face Mounting Legal Risks in 2026
Learn AI hiring legal risks in 2026: bias lawsuits like Mobley v. Workday, FCRA claims vs. Eightfold, state laws, and compliance strategies for audits, vendor due diligence.
NEC 2023 updates strain aging electrical systems with smart tech – risking fines for property owners
Understand why NEC 2023 updates for surge protection, EV chargers, and IoT overload aging systems, risking fines for property owners. Learn compliance audits, upgrades, and steps to mitigate penalties.
FDA Warning Crushes ExThera Blood Filter Sales
Understand FDA’s warning letter to ExThera over Seraph 100 blood filter violations: unapproved marketing claims, compassionate use failures, and compliance steps for device makers.
SEC OKs FINRA Gift Limit: $100 to $300 Boost
Understand SEC-approved FINRA Rule 3220 amendments raising gift limit from $100 to $300, codifying exclusions, valuation, aggregation rules and compliance steps for broker-dealers. (154 characters)
Treasury’s AI risk tools for financial services: the lexicon, FS AI RMF
Learn Treasury’s AI Risk Management Framework, Lexicon and FS AI RMF: tools adapting NIST standards for financial services to manage risks in cybersecurity, fraud, and governance while enabling secure innovation.
FDA Speeds Rare Disease Approvals: Biotech Boom Ahead
Understand FDA’s Plausible Mechanism Framework: draft guidance enables single-trial approvals for ultra-rare genetic therapies using mechanistic evidence, natural history data, and post-approval monitoring.
EU AML Simplification: Boosting Business Efficiency
Understand why the EU is simplifying AML rules via AMLA and Single Rulebook: harmonized CDD, reduced burdens, risk-based compliance, and 2026-2028 impacts for businesses. (154 characters)